Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Hold” by Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received an average recommendation of “Hold” from the eleven brokerages that are covering the stock, Marketbeat reports. Six research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $11.0625.

AVAH has been the topic of several research reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. William Blair initiated coverage on Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating on the stock. Barclays upped their price target on Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a report on Friday. Royal Bank Of Canada boosted their target price on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the stock a “sector perform” rating in a research report on Thursday. Finally, BMO Capital Markets initiated coverage on shares of Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 target price for the company.

Aveanna Healthcare Price Performance

AVAH opened at $9.22 on Friday. Aveanna Healthcare has a 52-week low of $3.67 and a 52-week high of $10.32. The company has a 50 day moving average of $8.83 and a two-hundred day moving average of $7.78. The company has a market cap of $1.93 billion, a P/E ratio of 25.61 and a beta of 2.06. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, November 6th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.08. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The business had revenue of $621.94 million for the quarter, compared to analyst estimates of $578.57 million. On average, analysts expect that Aveanna Healthcare will post -0.06 earnings per share for the current year.

Insider Activity

In related news, CAO Deborah Stewart sold 11,962 shares of the company’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $93,901.70. Following the sale, the chief accounting officer directly owned 251,676 shares of the company’s stock, valued at $1,975,656.60. This represents a 4.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Patrick A. Cunningham sold 12,445 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $7.85, for a total transaction of $97,693.25. Following the transaction, the insider directly owned 293,354 shares in the company, valued at $2,302,828.90. The trade was a 4.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,857,606 shares of company stock worth $295,491,307 over the last quarter. Corporate insiders own 7.80% of the company’s stock.

Institutional Trading of Aveanna Healthcare

Hedge funds have recently bought and sold shares of the company. Quantbot Technologies LP acquired a new position in shares of Aveanna Healthcare during the second quarter worth approximately $43,000. Diversified Trust Co acquired a new position in Aveanna Healthcare during the 2nd quarter worth $57,000. MQS Management LLC acquired a new position in Aveanna Healthcare during the 2nd quarter worth $59,000. Belvedere Trading LLC bought a new position in shares of Aveanna Healthcare in the second quarter worth $62,000. Finally, Oxford Asset Management LLP acquired a new position in shares of Aveanna Healthcare during the second quarter valued at $64,000. 87.96% of the stock is currently owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.